GlassScriptPhysician profile
Timothy Joseph Burroughs
NPI 1245557735
$14,759.31
in general payments reported to CMS, 2019-2025
34 companies · $2,781 in 2025
The $2,781 reported for 2025 was more than what 87% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,714 · 2020: $916 · 2021: $1,954 · 2022: $1,684 · 2023: $1,928 · 2024: $1,781 · 2025: $2,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,566 · Travel and Lodging: $924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,566.23 |
| Travel and Lodging | $923.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,806.14 | 2019-2025 | General - Therapies, Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $3,662.09 | 2019-2025 | Proclaim, Eterna |
| Medtronic USA, INC. | $3,339.24 | 2019-2020 | |
| Abbvie INC. | $944.23 | 2022-2025 | Botox, Ubrelvy, Qulipta |
| Medtronic, INC. | $693.00 | 2021-2024 | Intellis Adaptivestim, Synchromedii |
| Relievant Medsystems, INC. | $572.27 | 2021-2023 | Intracept |
| Nevro Corp. | $291.18 | 2019-2024 | Senza |
| Vertos Medical, INC. | $234.25 | 2020-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $178.14 | 2025 | Prospera |
| Curonix LLC | $170.60 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Teva Pharmaceuticals USA, INC. | $149.23 | 2019-2020 | |
| Allergan, INC. | $78.14 | 2020 | |
| Collegium Pharmaceutical, INC. | $60.89 | 2023-2024 | Belbuca, Xtampza |
| Assertio Therapeutics, INC. | $54.56 | 2019 | |
| Stimwave Technologies Incorporated | $46.02 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Protega Pharmaceutials INC | $44.16 | 2022 | |
| Saluda Medical Americas, INC. | $36.76 | 2024 | Evoke |
| Foundation Fusion Solutions, LLC | $36.58 | 2025 | |
| Stryker Corporation | $33.20 | 2025 | Omnicurve |
| Globus Medical, INC. | $29.86 | 2025 | Senza |
| Zyla Life Sciences, INC. | $28.76 | 2019-2020 | |
| Amgen INC. | $28.04 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $28.01 | 2021 | |
| Bioventus LLC | $25.97 | 2019 | |
| Almatica Pharma LLC | $25.56 | 2021 | |
| Innovation Technologies INC | $24.62 | 2024 | Irrisept |
| Janssen Pharmaceuticals, INC | $22.24 | 2024 | Xarelto |
| Spr Therapeutics, INC | $19.71 | 2024 | Sprint Pns System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.45 | 2024 | Relistor |
| Nalu Medical, INC. | $17.12 | 2024 | Nalu Neurostimulation System |
| Novartis Pharmaceuticals Corporation | $16.91 | 2020 | |
| Pfizer INC. | $16.68 | 2023 | |
| Kaleo, INC. | $14.14 | 2019 | |
| Lilly USA, LLC | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Burroughs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.